凡德他尼的合成工艺研究
Study on Synthetic Process of Vandetanib

DOI: 10.12677/SSC.2015.32005, PP. 28-34

Keywords: 凡德他尼，VEGFR抑制剂，喹唑啉，合成，抗肿瘤
Vandetanib, VEGFR Inhibitor, Quinazoline, Synthesis, Anticancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的：提供一条合成凡德他尼新工艺路线。方法：以香兰素为起始原料，经过酚羟基苄基保护、氧化、硝化、还原、环合和氯代反应得到7-苄氧基-4-氯-6-甲氧基喹唑啉，再与2-氟-4-溴苯胺发生取代反应，然后脱苄基生成4-(2-氟-4-溴苯胺基)-6-甲氧基-7-羟基喹唑啉(10)，收率33.1%；以4-哌啶甲酸乙酯为原料，经Leuckart N-甲基化反应、酯基还原反应，然后和对甲苯磺酰氯反应生成磺酸酯(14)，收率35.1%。最后将(10)和(14)在碱性条件下缩合得到目标产物凡德他尼(1)。(1)的总收率11.6% (以化合物(2)和(11)计)。结果：目标化合物及其中间体的化学结构都经过IR、1H-NMR和HR-MS图谱确证。结论：本方法缩短了反应步骤，反应条件温和、操作简便。
Objective: To develop a new synthetic route for Vandetanib. Methods: 4-(2-fluoro-4-bromo-ami- no)-6-methoxy-7-hydroxy-quinazoline (10) was prepared from vanillin (2) via phenolic hydroxyl protection, oxidation, nitration, reduction, cyclization and chlorination to afford 7-benzyloxy-4- chloro-6-methoxy-quinazoline (7), and then (7) coupled with 2-fluoro-4-bromoaniline, followed by debenzylation, yield 33.1%. (1-methylpiperidin-4-yl)methyl 4-methylbenzenesulfonate (14) was prepared from ethyl piperidine-4-carboxylate(11) by Leuckart reaction, reduction and then reacted with p-toluenesulfonyl chloride, yielding 35.1%. In addition, 10 was reacted with 14 to yield the antitumor drug vandetanib (1) with an overall yield of 11.6% (based on compound 2 and 11). Results: The structure of all products was confirmed by IR, 1H-NMR and HR-MS. Conclusion: The improved process has several advantages over those reported procedures, such as brief reac-tion steps, mild conditions, and simple operations.

References

[1]	Bruns, C.J., Solorzano, C.C., Harbison, M.T., et al. (2000) Blockade of the epidermal growth factor receptor signaling by a novel tyrosine Kinase inhitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Research, 60, 2926.
[2]	Ciardiello, F., Caputo, R., Bianco, R., et al. (2001) Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine Kinase inhibitor. Clinic Cancer Research, 7, 1459.
[3]	Li, Y., Zhang, X.R., et al. (2006) The multitargeted anti-tumor new angent: ZD6474. Oncology Progress, 4, 206-210.
[4]	Thomas, G., et al. (2010) Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases. WO Patent No. 2010028254.
[5]	Hennequin, L.F., Thomas, A.P., et al. (1999) Design and structure-activity relationship of a new class of potent VEGF receptor tyrosine kinase inhibitors. Journal of Medicinal Chemistry, 42, 5369-5389.
[6]	Althuis, T.H., Hess, H.J., et al. (1977) Synthesis and identification of the major metabolites of prazosin formed in dog and rat. Journal of Medicinal Chemistry, 20, 146-149.
[7]	Li, H.-H., Huang, H., Zhang, X.-H., et al. (2008) Discovering novel 3-nitroquinolines as a new class of anticancer agents. Acta Pharmacologica Sinica, 29, 1529-1538. http://dx.doi.org /10.1111/j.1745-7254.2008.00907.x
[8]	Kamal, A., Narayan Reddy, B.S., et al. (2002) Design and Synthesis of C-8 Linked PyrrolobenzodiazepineNaphthalimide Hybrids as Anti-TumourAgents. Bioorganic & Medicinal Chemistry Letters, 12, 1933-1935. http://dx.doi.org /10.1016/S0960-894X(02)00326-8
[9]	Wang, J.L., Chen, G.H., Liu, K.C., et al. (2009) N-(4-溴-2-氟苯)-6-甲氧基-7-[2(1H-1,2,3-1-三唑)乙氧基]-4-喹唑啉胺盐酸盐的合成与应用. 中国专利: CN 100554265C.
[10]	Periasamy, M., Thirumalaikumar, M., et al. (2000) Methods of enhancement of reactivity and selectivity of sodium borohydride for applications in organic synthesis. Journal of Organometallic Chemistry, 609, 137-151. http://dx.doi.org /10.1016/S0022-328X(00)00210-2
[11]	Yamakawa, T., Masaki, M., et al. (1991) A new reduction of some carboxylic esters with sodium borohydride and zinc chloride in the presence of a tertiary amine. Bulletin of the Chemical Society of Japan, 64, 2730-2734. http://dx.doi.org /10.1246/bcsj.64.2730
[12]	王亚楼, 徐进宜, 文国清 (1999) 高香草酸的合成. 中国药科大学学报, 3, 237-238.
[13]	Thurston, D.E., Murty, V.S., et al. (1990) O-Debenzylation of a pyrrolo[2,1-c][1,4]benzodiazepine in the presence of a carbinolamine functionality: Synthesis of DC-81. Synthesis, 1, 81-84.
[14]	Schlosser, M., Ginanneschi, A., et al. (2006) In search of simplicity and flexibility: A rational access to twelve fluoroindolecarboxylic acids. European Journal of Organic Chemistry, 13, 2956-2969.

Full-Text